CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −5,376 | $536.78 | $2.9M | 58,744 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −3,069 | $537.84 | $1.7M | 55,705 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −500 | $538.83 | $269K | 55,205 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −300 | $540.82 | $162K | 54,905 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −583 | $542.08 | $316K | 54,322 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −100 | $543.14 | $54K | 54,222 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −25,000 | 24,002 | ||
| 2021-02-16 | Claflin Bruce L. Director | Exercise or conversion | +5,902 | $85.00 | $502K | 6,206 |
| 2021-02-16 | Claflin Bruce L. Director | Exercise or conversion | +1,125 | $160.28 | $180K | 7,331 |
| 2021-02-16 | Claflin Bruce L. Director | Sale | −6,745 | $536.89 | $3.6M | 586 |
| 2021-02-16 | Claflin Bruce L. Director | Sale | −586 | $537.19 | $315K | 0 |
| 2021-02-16 | Claflin Bruce L. Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −5,902 | 0 | ||
| 2021-02-16 | Claflin Bruce L. Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −1,125 | 1,921 | ||
| 2021-02-05 | AYERS JONATHAN W Director | Gift | −8,000 | 652,737 |
Page 74 of 74 · 1,474 trades